Carlos Suñé

Dr. Carlos Suñé

orcid

Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 1992 in Virology
Verified
Journal Article
Closed access
CSCarlos M. Sánchez
Carlos M. Sánchez
FGFatima Gebauer
Fatima Gebauer
CSCarlos Suñé
Carlos Suñé
AMAna Méndez
Ana Méndez
JDJoaquin Dopazo
Joaquin Dopazo
Luis EnjuanesLuis Enjuanes
Luis Enjuanes

1 February 1990 in Virology
Verified
Journal Article
Closed access
CSCarlos M. Sánchez
Carlos M. Sánchez
GJGustavo Jiménez
Gustavo Jiménez
MLMaría D. Laviada
María D. Laviada
ICIsabel Correa
Isabel Correa
CSCarlos Suñé
Carlos Suñé
Luis EnjuanesLuis Enjuanes
Luis Enjuanes

1 October 1997 in Molecular and Cellular Biology
Verified
Journal Article
Open access
PDF file
CSCarlos Suñé
Carlos Suñé
THTakuma Hayashi
Takuma Hayashi
YLYi Liu
Yi Liu
WLWilliam S. Lane
William S. Lane
RYRichard A. Young
Richard A. Young
MGMariano A. Garcia-Blanco
Mariano A. Garcia-Blanco
Maximal human immunodeficiency virus type 1 (HIV-1) gene expression requires specific cellular factors in addition to the virus-encoded trans-activator protein Tat and the RNA element TAR. We developed a functional assay, based on transcriptional activation in vitro, to identify these cellular factors. Here, we describe the purification and molecular cloning of CA150, a nuclear protein that is associated with the human RNA polymerase II holoenzyme and is involved in Tat-dependent HIV-1 transcriptional activation. The sequence of CA150 contains an extensive glutamine- and alanine-rich repeat that is found in transcriptional modulators such as GAL11 and SSN6 in Saccharomyces cerevisiae and Zeste in Drosophila melanogaster. Immunodepletion of CA150 abolished Tat trans activation in vitro. Moreover, overexpression of a mutant CA150 protein specifically and dramatically decreased Tat-mediated activation of the HIV-1 promoter in vivo, strongly suggesting a role for CA150 in HIV-1 gene regulation. Immunoprecipitation experiments demonstrated that both CA150 and Tat associate with the RNA polymerase II holoenzyme. Furthermore, we found that functional Tat associates with the holoenzyme whereas activation-deficient Tat mutants do not. Thus, we propose that Tat action is transduced via an RNA polymerase II holoenzyme that contains CA150.

25 July 2000 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
SCSherry M. Carty
Sherry M. Carty
AGAaron C. Goldstrohm
Aaron C. Goldstrohm
CSCarlos Suñé
Carlos Suñé
MGMariano A. Garcia-Blanco
Mariano A. Garcia-Blanco
AGArno L. Greenleaf
Arno L. Greenleaf
An approach for purifying nuclear proteins that bind directly to the hyperphosphorylated C-terminal repeat domain (CTD) of RNA polymerase II was developed and used to identify one human phosphoCTD-associating protein as CA150. CA150 is a nuclear factor implicated in transcription elongation. Because the hyperphosphorylated CTD is a feature of actively transcribing RNA polymerase II (Pol II), phosphoCTD (PCTD) binding places CA150 in a location appropriate for performing a role in transcription elongation-related events. Several recombinant segments of CA150 bound the PCTD. Predominant binding is mediated by the portion of CA150 containing six FF domains, compact modules of previously unknown function. In fact, small recombinant proteins containing the fifth FF domain bound the PCTD. PCTD binding is the first specific function assigned to an FF domain. As FF domains are found in a variety of nuclear proteins, it is likely that some of these proteins are also PCTD-associating proteins. Thus FF domains appear to be compact protein-interaction modules that, like WW domains, can be evolutionarily shuffled to organize nuclear function.

1 June 2012 in Gene
Verified
Journal Article
Closed access
MMMarta Montes
Marta Montes
SBSoraya Becerra
Soraya Becerra
MSMiguel Sanchez-Alvarez
Miguel Sanchez-Alvarez
CSCarlos Suñé
Carlos Suñé

1 April 1988 in Virus Research
Verified
Journal Article
Closed access
ICIsabel Correa
Isabel Correa
GJGustavo Jiménez
Gustavo Jiménez
CSCarlos Suñé
Carlos Suñé
MBMaria Jesus Bullido
Maria Jesus Bullido
Luis EnjuanesLuis Enjuanes
Luis Enjuanes